3-(3H-benzimidazol-5-yl)-1-[1-(1,3-benzodioxol-5-yl)-1,3,4,9-tetrahydropyrido[3,4-b]indol-2-yl]propan-1-one

C28H24N4O3 — CID 21022411

IUPAC3-(3H-benzimidazol-5-yl)-1-[1-(1,3-benzodioxol-5-yl)-1,3,4,9-tetrahydropyrido[3,4-b]indol-2-yl]propan-1-one
SMILESO=C(CCc1ccc2nc[nH]c2c1)N1CCc2c([nH]c3ccccc23)C1c1ccc2c(c1)OCO2
InChIInChI=1S/C28H24N4O3/c33-26(10-6-17-5-8-22-23(13-17)30-15-29-22)32-12-11-20-19-3-1-2-4-21(19)31-27(20)28(32)18-7-9-24-25(14-18)35-16-34-24/h1-5,7-9,13-15,28,31H,6,10-12,16H2,(H,29,30)
InChIKeyJFFDWHGEXKLKAO-UHFFFAOYSA-N
MW464.53 g/mol
LogP4.88
Rot. Bonds4

About 3-(3H-benzimidazol-5-yl)-1-[1-(1,3-benzodioxol-5-yl)-1,3,4,9-tetrahydropyrido[3,4-b]indol-2-yl]propan-1-one

3-(3H-benzimidazol-5-yl)-1-[1-(1,3-benzodioxol-5-yl)-1,3,4,9-tetrahydropyrido[3,4-b]indol-2-yl]propan-1-one (PubChem CID 21022411) has the molecular formula C28H24N4O3 and a molecular weight of 464.53 g/mol. Its IUPAC name is 3-(3H-benzimidazol-5-yl)-1-[1-(1,3-benzodioxol-5-yl)-1,3,4,9-tetrahydropyrido[3,4-b]indol-2-yl]propan-1-one.

Molecular Properties

Compound Name3-(3H-benzimidazol-5-yl)-1-[1-(1,3-benzodioxol-5-yl)-1,3,4,9-tetrahydropyrido[3,4-b]indol-2-yl]propan-1-one
PubChem CID21022411
Molecular FormulaC28H24N4O3
Molecular Weight464.53 g/mol
Exact Mass464.18
IUPAC Name3-(3H-benzimidazol-5-yl)-1-[1-(1,3-benzodioxol-5-yl)-1,3,4,9-tetrahydropyrido[3,4-b]indol-2-yl]propan-1-one
SMILESO=C(CCc1ccc2nc[nH]c2c1)N1CCc2c([nH]c3ccccc23)C1c1ccc2c(c1)OCO2
InChIInChI=1S/C28H24N4O3/c33-26(10-6-17-5-8-22-23(13-17)30-15-29-22)32-12-11-20-19-3-1-2-4-21(19)31-27(20)28(32)18-7-9-24-25(14-18)35-16-34-24/h1-5,7-9,13-15,28,31H,6,10-12,16H2,(H,29,30)
InChIKeyJFFDWHGEXKLKAO-UHFFFAOYSA-N
XLogP4.88
TPSA83.24 Ų
H-Bond Donors2
H-Bond Acceptors4
Rotatable Bonds4
Heavy Atoms35
Complexity

Lipinski Rule of Five

Passes Rule of Five

RuleValue
MW ≤ 500464.53
LogP ≤ 54.88
H-Bond Donors ≤ 52
H-Bond Acceptors ≤ 104

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'indol_3yl_alk(461)', 'substructure': 'N/A'}

Analyze 3-(3H-benzimidazol-5-yl)-1-[1-(1,3-benzodioxol-5-yl)-1,3,4,9-tetrahydropyrido[3,4-b]indol-2-yl]propan-1-one with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of 3-(3H-benzimidazol-5-yl)-1-[1-(1,3-benzodioxol-5-yl)-1,3,4,9-tetrahydropyrido[3,4-b]indol-2-yl]propan-1-one?
The IUPAC name of 3-(3H-benzimidazol-5-yl)-1-[1-(1,3-benzodioxol-5-yl)-1,3,4,9-tetrahydropyrido[3,4-b]indol-2-yl]propan-1-one (CID 21022411) is 3-(3H-benzimidazol-5-yl)-1-[1-(1,3-benzodioxol-5-yl)-1,3,4,9-tetrahydropyrido[3,4-b]indol-2-yl]propan-1-one.
What is the SMILES notation for 3-(3H-benzimidazol-5-yl)-1-[1-(1,3-benzodioxol-5-yl)-1,3,4,9-tetrahydropyrido[3,4-b]indol-2-yl]propan-1-one?
The canonical SMILES for 3-(3H-benzimidazol-5-yl)-1-[1-(1,3-benzodioxol-5-yl)-1,3,4,9-tetrahydropyrido[3,4-b]indol-2-yl]propan-1-one is O=C(CCc1ccc2nc[nH]c2c1)N1CCc2c([nH]c3ccccc23)C1c1ccc2c(c1)OCO2.
What is the InChIKey of 3-(3H-benzimidazol-5-yl)-1-[1-(1,3-benzodioxol-5-yl)-1,3,4,9-tetrahydropyrido[3,4-b]indol-2-yl]propan-1-one?
The InChIKey is JFFDWHGEXKLKAO-UHFFFAOYSA-N. The full InChI is InChI=1S/C28H24N4O3/c33-26(10-6-17-5-8-22-23(13-17)30-15-29-22)32-12-11-20-19-3-1-2-4-21(19)31-27(20)28(32)18-7-9-24-25(14-18)35-16-34-24/h1-5,7-9,13-15,28,31H,6,10-12,16H2,(H,29,30).
What are the key properties of 3-(3H-benzimidazol-5-yl)-1-[1-(1,3-benzodioxol-5-yl)-1,3,4,9-tetrahydropyrido[3,4-b]indol-2-yl]propan-1-one?
3-(3H-benzimidazol-5-yl)-1-[1-(1,3-benzodioxol-5-yl)-1,3,4,9-tetrahydropyrido[3,4-b]indol-2-yl]propan-1-one has a molecular weight of 464.53 g/mol, XLogP of 4.88, 4 rotatable bonds, 2 hydrogen bond donors, and 4 hydrogen bond acceptors.
Where does this data come from?
All data for 3-(3H-benzimidazol-5-yl)-1-[1-(1,3-benzodioxol-5-yl)-1,3,4,9-tetrahydropyrido[3,4-b]indol-2-yl]propan-1-one is sourced from PubChem (CID 21022411), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).